Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara Felicioni

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Human Mutation|May 23, 2009
Molecular profiling of the "plexinome" in melanoma and pancreatic cancerAsha Balakrishnan, Junia Y Penachioni, Simona Lamba, et al.
Plos One|August 20, 2014
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatmentAntonio Marchetti, Maela Del Grammastro, Lara Felicioni, et al.
The EMBO Journal|June 13, 2009
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathwayFrancesca Mancini, Giusy Di Conza, Marsha Pellegrino, et al.
Plos One|August 1, 2012
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implicationsAntonio Marchetti, Maela Del Grammastro, Giampaolo Filice, et al.
International Journal of Cancer|September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar featuresFiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Cancer Research|November 4, 2005
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilizationSimona Giglio, Francesca Mancini, Francesca Gentiletti, et al.
Oncotargets and Therapy|April 17, 2019
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practiceAlessio Cortellini, Katia Cannita, Alessandro Parisi, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clonesAntonio Marchetti, Michele Milella, Lara Felicioni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapyMichele Milella, Carmen Nuzzo, Emilio Bria, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Human Mutation|May 23, 2009
Molecular profiling of the "plexinome" in melanoma and pancreatic cancerAsha Balakrishnan, Junia Y Penachioni, Simona Lamba, et al.
Plos One|August 20, 2014
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatmentAntonio Marchetti, Maela Del Grammastro, Lara Felicioni, et al.
The EMBO Journal|June 13, 2009
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathwayFrancesca Mancini, Giusy Di Conza, Marsha Pellegrino, et al.
Plos One|August 1, 2012
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implicationsAntonio Marchetti, Maela Del Grammastro, Giampaolo Filice, et al.
International Journal of Cancer|September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar featuresFiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Cancer Research|November 4, 2005
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilizationSimona Giglio, Francesca Mancini, Francesca Gentiletti, et al.
Oncotargets and Therapy|April 17, 2019
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practiceAlessio Cortellini, Katia Cannita, Alessandro Parisi, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clonesAntonio Marchetti, Michele Milella, Lara Felicioni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapyMichele Milella, Carmen Nuzzo, Emilio Bria, et al.
Pageof 4